Consensus Abbott Laboratories

Stocks

ABT

US0028241000

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX 12:06:01 23/10/2026 am IST			5-day change	1st Jan Change
102.44 ^USD	+1.92%		-1.97%	-18.09%

10:24pm	Abbott Laboratories' Q3 Somewhat a 'Mixed Bag' With Softened Outlook, Nutrition Spinoff, Oppenheimer Says	MT
09:47pm	Abbott Laboratories' 2026 Guidance Cut Driven by Diabetes, Electrophysiology Portfolio, RBC Says	MT

Evolution of the Average Target: Abbott Laboratories

Evolution of the Target Price: Abbott Laboratories

Changes in Analyst Recommendations: Abbott Laboratories

e16779a3cb50464df5db4ee.Ni0k0Q-SvotqZcafyngeo0jOKKmsQDUF3LtkcUP8dtU.D0V0qEWm5-w8N4rUgB1GkgKFUcf9FWJ0mdMoRiiMO7wFZ3eaVvvL-i8K8g~2155e5316ad86467a18332f0cc2c14c1

Analysts' recommendations: Abbott Laboratories

09:47pm	Abbott Laboratories' 2026 Guidance Cut Driven by Diabetes, Electrophysiology Portfolio, RBC Says	MT
06:55pm	Jefferies & Co Adjusts Abbott Laboratories Price Target to $130 From $135	MT
04:32pm	RBC Trims Price Target on Abbott Laboratories to $125 From $130, Keeps Outperform Rating	MT
03:28pm	Leerink Partners Adjusts Price Target on Abbott Laboratories to $106 From $109	MT
03:27pm	BTIG Adjusts Price Target on Abbott Laboratories to $125 From $134	MT
03:27pm	Wells Fargo Adjusts Price Target on Abbott Laboratories to $119 From $112	MT
03:26pm	JPMorgan Adjusts Price Target on Abbott Laboratories to $118 From $120	MT
03:26pm	TD Cowen Adjusts Price Target on Abbott Laboratories to $118 From $135	MT
20/10	Abbott Laboratories' Established Pharma Unit Undervalued on Biosimilars Potential, UBS Says	MT
07/10	Barclays Initiates Coverage on Abbott Laboratories With Overweight Rating, $120 Price Target	MT
05/10	Evercore ISI Adjusts Price Target on Abbott Laboratories to $124 From $120, Keeps Outperform Rating	MT
02/10	Rothschild & Co Redburn Upgrades Abbott Laboratories to Buy From Neutral, Adjusts PT to $127 From $119	MT
02/10	Rothschild & Co Redburn Upgrades Abbott Laboratories to Buy From Neutral, Adjusts PT to $127 From $119	MT
02/10	Analyst recommendations: Airbnb, Hewlett Packard Enterprise, Fair Isaac, Nike…
21/08	TD Cowen Adjusts Price Target on Abbott Laboratories to $135 From $115, Maintains Buy Rating	MT
13/08	Citigroup Adjusts Price Target on Abbott Laboratories to $125 From $112, Maintains Buy Rating	MT
13/08	Wolfe Research Upgrades Abbott Laboratories to Outperform From Peer Perform, PT is $130	MT
28/07	UBS Adjusts Price Target on Abbott Laboratories to $125 From $135, Maintains Buy Rating	MT
28/07	Rothschild & Co Redburn Adjusts PT on Abbott Laboratories to $119 From $126, Maintains Neutral Rating	MT
23/07	Daiwa Securities Adjusts Price Target on Abbott Laboratories to $103 From $92, Maintains Neutral Rating	MT
22/07	Leerink Partners Adjusts Price Target on Abbott Laboratories to $109 From $106, Maintains Market Perform Rating	MT
17/07	Abbott Laboratories Seen on Track for H2 Growth Acceleration, RBC Says	MT
17/07	JPMorgan Adjusts Price Target on Abbott Laboratories to $120 From $110, Maintains Overweight Rating	MT
17/07	Piper Sandler Adjusts Price Target on Abbott Laboratories to $118 From $115, Maintains Overweight Rating	MT
17/07	BTIG Adjusts Price Target on Abbott Laboratories to $134 From $131, Maintains Buy Rating	MT

More recommendations

Other Medical Equipment, Supplies & Distribution

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	ABBOTT LABORATORIES					+18.95%
	STRYKER CORPORATION					+21.85%
	MEDTRONIC PLC					+12.45%
	ESSILORLUXOTTICA					+23.1%
	CENCORA, INC.					+8.42%
	HOYA CORPORATION					+15.54%
	BECTON, DICKINSON AND COMPANY					+0.63%
	IDEXX LABORATORIES, INC.					+26.11%
	ALCON INC.					+33.74%
	MEDLINE INC.					+25.81%
	Average					+18.66%
	Weighted average by Cap.					+17.82%